migraine Archives - LifeScienceHistory.com

Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for Acute Treatment of Migraine

Disease | FDA | Neurology | Pharmaceutical | Therapeutics

Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for Acute Treatment of Migraine

On May 15, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Brekiya®…

FDA approved Lundbeck’s VYEPTI™ – the first and only intravenous preventive treatment for migraine

Biotechnology | Disease | Neurology | Pharmaceutical | Therapeutics

FDA approved Lundbeck’s VYEPTI™ – the first and only intravenous preventive treatment for migraine

On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…

Lundbeck acquired Alder BioPharmaceuticals for $1.95 billion

Biotechnology | Disease | Neurology | Pharmaceutical | Therapeutics

Lundbeck acquired Alder BioPharmaceuticals for $1.95 billion

On Oct. 22, 2019, Lundbeck, located in Valby, Denmark, announced it had completed its acquisition of Bothell, Washington-based…

$10 million gift to UCLA from Wendy and Leonard Goldberg largest ever to support migraine research

Biotechnology | Neurology | Non-Profit Research | Therapeutics

$10 million gift to UCLA from Wendy and Leonard Goldberg largest ever to support migraine research

On Dec. 8, 2015, the University of California, Los Angeles ( UCLA) Health Sciences announced it had received…